Your Article Summary
See Latest ArticlesEuropean Approval for UCB's Cimzia
PharmExec, 06/29/09
Europe's drug watchdog has recommended EU approval of UCB's rheumatoid arthritis treatment Cimzia. UCB said that the drug will be made available in the Europe before the end of the year and is now only awaiting marketing authorisation from the EU. Cimzia belongs to a class of drugs that block an inflammatory protein known as a tumour necrosis factor.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09